Cargando…

Evaluating the Time Toxicity of Cancer Treatment in the CCTG CO.17 Trial

The time spent in pursuing treatments for advanced cancer can be substantial. We have previously proposed a pragmatic and patient-centered metric of these time costs—which we term time toxicity—as any day with physical health care system contact. This includes outpatient visits (eg, bloodwork, scans...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gupta, Arjun, O'Callaghan, Christopher J., Zhu, Liting, Jonker, Derek J., Wong, Ralph P.W., Colwell, Bruce, Moore, Malcolm J., Karapetis, Christos S., Tebbutt, Niall C., Shapiro, Jeremy D., Tu, Dongsheng, Booth, Christopher M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2023
Materias:	ORIGINAL CONTRIBUTIONS
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10337749/ https://www.ncbi.nlm.nih.gov/pubmed/36881786 http://dx.doi.org/10.1200/OP.22.00737

Ejemplares similares

Clustering on longitudinal quality‐of‐life measurements using growth mixture models for clinical prognosis: Implementation on CCTG/AGITG CO.20 trial
por: Zhang, Jiahui, et al.
Publicado: (2022)

Fc‐gamma receptor polymorphisms, cetuximab therapy, and overall survival in the CCTG CO.20 trial of metastatic colorectal cancer
por: Shepshelovich, Daniel, et al.
Publicado: (2018)

Contact Days Associated With Cancer Treatments in the CCTG LY.12 Trial
por: Gupta, Arjun, et al.
Publicado: (2023)

Neoadjuvant Chemotherapy, Excision, and Observation for Early Rectal Cancer: The Phase II NEO Trial (CCTG CO.28) Primary End Point Results
por: Kennecke, Hagen F., et al.
Publicado: (2023)

The CCTG PA.7 phase II trial of gemcitabine and nab-paclitaxel with or without durvalumab and tremelimumab as initial therapy in metastatic pancreatic ductal adenocarcinoma
por: Renouf, Daniel J., et al.
Publicado: (2022)

The origin of genetic instability in CCTG repeats
por: Lam, Sik Lok, et al.
Publicado: (2011)

Germline Polymorphisms as Biomarkers of Tumor Response in Colorectal Cancer Patients Treated with Anti-EGFR Monoclonal Antibodies: A Systematic Review and Meta-Analysis
por: Morgen, Eric K, et al.
Publicado: (2017)

Does the Chemotherapy Backbone Impact on the Efficacy of Targeted Agents in Metastatic Colorectal Cancer? A Systematic Review and Meta-Analysis of the Literature
por: Chan, David L., et al.
Publicado: (2015)

Correction: Does the Chemotherapy Backbone Impact on the Efficacy of Targeted Agents in Metastatic Colorectal Cancer? A Systematic Review and Meta-Analysis of the Literature
por: Chan, David L., et al.
Publicado: (2015)

A randomized phase II study of pelareorep and docetaxel or docetaxel alone in men with metastatic castration resistant prostate cancer: CCTG study IND 209
por: Eigl, Bernhard Josef, et al.
Publicado: (2018)

Myotonic Dystrophy-2: Unusual Phenotype Due to a Small CCTG-expansion
por: Finsterer, J, et al.
Publicado: (2018)

Results of the phase I CCTG IND.231 trial of CX-5461 in patients with advanced solid tumors enriched for DNA-repair deficiencies
por: Hilton, John, et al.
Publicado: (2022)

The competing mini-dumbbell mechanism: new insights into CCTG repeat expansion
por: Guo, Pei, et al.
Publicado: (2016)

Impact of lymphopenia on survival for elderly patients with glioblastoma: A secondary analysis of the CCTG CE.6 (EORTC 26062-22061, TROG08.02) randomized clinical trial
por: Song, Andrew J, et al.
Publicado: (2021)

Corrigendum to: Impact of lymphopenia on survival for elderly patients with glioblastoma: A secondary analysis of the CCTG CE.6 (EORTC 26062-22061, TROG 08.02) randomized clinical trial
por: Song, Andrew J, et al.
Publicado: (2022)

Epiregulin gene expression as a biomarker of benefit from cetuximab in the treatment of advanced colorectal cancer
por: Jonker, D J, et al.
Publicado: (2014)

Advantages of the net benefit regression framework for trial-based economic evaluations of cancer treatments: an example from the Canadian Cancer Trials Group CO.17 trial
por: Hoch, Jeffrey S., et al.
Publicado: (2019)

Early detection of treatment futility in patients with metastatic colorectal cancer
por: Rattner, Jodi I., et al.
Publicado: (2022)

Clinical and metabolomic characterization of Brivanib‐Induced hypertension in metastatic colorectal cancer
por: Rattner, Jodi I., et al.
Publicado: (2023)

The role of biological therapy in metastatic colorectal cancer after first-line treatment: a meta-analysis of randomised trials
por: Segelov, E, et al.
Publicado: (2014)

Complementary Medicine Use Amongst Patients with Metastatic Cancer Enrolled in Phase III Clinical Trials
por: Wells, J Connor, et al.
Publicado: (2022)

Cancer Antigen 15-3/Mucin 1 Levels in CCTG MA.32: A Breast Cancer Randomized Trial of Metformin vs Placebo
por: Goodwin, Pamela J, et al.
Publicado: (2021)

The Management of Unresectable, Advanced Gastrointestinal Stromal Tumours
por: Foo, Tiffany, et al.
Publicado: (2022)

Two-stage multivariate Mendelian randomization on multiple outcomes with mixed distributions
por: Deng, Yangqing, et al.
Publicado: (2023)

The Unstable CCTG Repeat Responsible for Myotonic Dystrophy Type 2 Originates from an AluSx Element Insertion into an Early Primate Genome
por: Kurosaki, Tatsuaki, et al.
Publicado: (2012)

Massive contractions of Myotonic Dystrophy Type 2-associated CCTG tetranucleotide repeats occur via double strand break repair with distinct requirements for helicases
por: Papp, David, et al.
Publicado: (2023)

The Impact of Reoperations Following Bariatric Surgery on Mid-term Outcomes
por: Straatman, Jennifer, et al.
Publicado: (2023)

Circadian Blood Pressure Variations Computed From 1.7 Million Measurements in an Acute Hospital Setting
por: Mahdi, Adam, et al.
Publicado: (2019)

Circulating Tumor DNA Identifies Diverse Landscape of Acquired Resistance to Anti–Epidermal Growth Factor Receptor Therapy in Metastatic Colorectal Cancer
por: Topham, James T., et al.
Publicado: (2023)

The Diagnostic Evaluation of Risk Factors for Urinary Tract Stones: An Analysis of Care Patterns in Five Hospitals
por: Jekel, James F., et al.
Publicado: (1982)

Evaluating the Indirect Costs of Care Associated with Salvage Chemotherapy for Relapsed and Refractory Aggressive-Histology Lymphoma: A Subset Analysis of the Canadian Cancer Trials Group (CCTG) LY.12 Clinical Trial
por: Prica, Anca, et al.
Publicado: (2021)

OxMaR: Open Source Free Software for Online Minimization and Randomization for Clinical Trials
por: O’Callaghan, Christopher A.
Publicado: (2014)

Biology—The Path Ahead
por: O’Callaghan, Christopher A.
Publicado: (2011)

Paramedics’ Ability to Perform Drug Calculations
por: Eastwood, Kathryn J, et al.
Publicado: (2009)

New York Academy of Medicine: Section on Orthopaedic Surgery.—Meeting of Nov. 17, 1899
Publicado: (1900)

Homœopathy as It Was and Is: A Paper Read before the Chicago Medical Society, July 17, 1871
por: Earle, Charles W.
Publicado: (1871)

Optimising the management of children with concomitant bladder dysfunction and behavioural disorders
por: Eliezer, Dilharan D., et al.
Publicado: (2022)

Co-dependence of the neural and humoral pathways in the mechanism of remote ischemic conditioning
por: Pickard, Jack M. J., et al.
Publicado: (2016)

Uncontrolled IL-17 Production by Intraepithelial Lymphocytes in a Case of non-IPEX Autoimmune Enteropathy
por: Paroni, Moira, et al.
Publicado: (2016)

A New Look at T Cells
por: McMichael, Andrew J., et al.
Publicado: (1998)

Cannot write session to /tmp/vufind_sessions/sess_cgv3l3dbhc9ifk6ctkj16qct8i